Clinical trial · Observational
Institut Paoli Calmettes Colorectal Cancer Database
NCT02869503CI-TRIAL-00023514recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Database of Institut Paoli-Calmettes patients diagnosed with colorectal cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Neoplasms | Colorectal Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Data collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with colorectal cancer diagnosis
- interventionNames
- Other: Data collection
Primary outcomes (1)
- measure
- Survival of patients with colorectal cancer
- timeFrame
- 10 years
- description
- Overall survival of all patients who come in the center
Secondary outcomes (1)
- measure
- Collection of patients characteristics
- timeFrame
- 10 years
- description
- Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective or retrospective studies
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 95 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with a colorectal cancer diagnosis Exclusion Criteria: * Non applicable
References
Publications (1)
- DERIVEDMeillat H, Saadoun JE, Zemmour C, Illy M, Poizat F, Ratone JP, Dazza M, de Chaisemartin C, Lelong B. Short- and long-term impact of the TaTME learning process: a single institutional study. Tech Coloproctol. 2024 Dec 19;29(1):27. doi: 10.1007/s10151-024-03065-4. PMID 39702684